Intervention fidelity: Aspects of complementary and alternative medicine research

Cancer Nursing

Volumn 33, Issue 5, 2010, Pages 331-342

  Wyatt, Gwen ^a   Sikorskii, Alla ^a   Rahbar, Mohammad Hossein ^b   Victorson, David ^c   Adams, Lora ^d  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d McLaren Health System   (United States)

Author keywords

Complementary and alternative medicine; Dosing; Intervention delivery; Intervention fidelity; Interventionists consistency

Indexed keywords

PLACEBO;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; BREAST CANCER; CANCER RESEARCH; CANCER STAGING; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REFLEXOLOGY;

BREAST NEOPLASMS; CONCEPT FORMATION; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; MIDDLE AGED; MODELS, NURSING; PSYCHOMETRICS; QUALITY OF LIFE; REFLEXOTHERAPY;

EID: 77955230815     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/NCC.0b013e3181d0b4b7     Document Type: Article

References (59)

1. Badger T, Braden C, Mishel M, Longman AJ. Depression burden, psychological adjustment, and quality of life in women with breast cancer: patterns over time. Res Nurs Health. 2004;27:19-28.
2. Kenne Sarenmalm E, Ohlen J, Oden A, Gaston-Johansson F. Experience and predictors of symptoms, distress and health-related quality of life over time in postmenopausal women with recurrent breast cancer. Psychooncology. 2008;17(5):497-505.
3. Hann DM, Baker R, Roberts CS, et al. Use of complementary therapies among breast and prostate cancer patients during treatment: a multisite study. Integr Cancer Ther. 2005;4(4):294-300.
4. Morris KT, Johnson N, Homer L, Walts D. A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg. 2000;179(5):407-411.
5. Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health. 2007;7(4). http://www.biomedcentral. com/content/pdf/1472-6874-7-4.pdf. Accessed October 15, 2009.
6. Lengacher C, Bennett M, Kip K, et al. Frequency of use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum. 2002;29(10):1445-1452.
7. Matthews AK, Sellergren SA, Huo D, List M, f leming G. Complementary and alternative medicine use among breast cancer survivors. J Altern Complement Med. 2007;13(5):555-562.
8. Berman JD, Straus SE. Implementing a research agenda for complementary and alternative medicine. Annu Rev Med. 2004;55:239-254.
9. National Institutes of Health. National Center for Complementary and Alternative Medicine. http://nccam.nih.gov/health/whatiscam/. Accessed July 1, 2009.
10. Mehling W, DiBlasi Z, Hecht F. Bias control in trials of bodywork: a review of methodological issues. J Altern Complement Med. 2005;11(2): 333-342.
11. Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials. JAMA. 2001;285(15):1192-1195.
12. Buchanan DR, White JD, O,Mara AM, Kelaghan JW, Smith WB, Minasian LM. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute community clinical oncology program experience. J Clin Oncol. 2005;23(27):6682-6689.
13. Efficace F, Horneber M, Lejeune S, et al. Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology. J Clin Epidemiol. 2006;59:1257-1265.
14. Kopelman LM. The role of science in assessing conventional, complementary, and alternative medicines. In: Callaghan D, ed. The Role of Complementary and Alternative Medicine: Accommodating Pluralism. Washington, DC: Georgetown University Press; 2002:36-53.
15. Chan EKH, O'Neill I, McKenzie M, Love A, Kissane DW. What works for therapists conducting family meetings: treatment integrity in familyfocused grief therapy during palliative care and bereavement. J Pain Symptom Manage. 2004;27(6):502-512.
16. Bellg AJ, borrelli B, Resnick B, et al. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol. 2004;23(5):443-451.
17. Radziewicz RM, Rose JH, Bowman KF, Berila RA, O'Toole EE, Given B. Establishing treatment fidelity in a coping and communication support telephone intervention for aging patients with advanced cancer and their family caregivers. Cancer Nurs. 2009;32(3):193-202.
18. Wyatt GK, Sikorskii A, Rahbar H. Reflexology: An Intervention for Advanced Breast Cancer: Michigan State University funded by the National Cancer Institute; 2005-2010. 1R01 CA104883-01A1.
19. Byers DC. Better Health with Foot Ref lexology: The Original Ingham Method. St Petersburg, f l: Ingham Publishing, Inc; 1996.
20. Pirovano M, Maltonia M, Nanni O, et al. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. J Pain Symptom Manage. 1999;1(9):231-239. (Pubitemid 29159965)
21. Taves DR. Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther. 1974;15:443-453.
22. SAS Software. Version 9 of the SAS System for Windows. Cary, NC: SAS Institute Inc; 2002-2003. Copyright 2002-2003 SAS Institute Inc SAS and all other SAS Institute Inc product or service names are registered trademarks or trademarks of SAS Institute Inc.
23. Cella DF, Bonomi AE. Manual Functional Assessment of Cancer Therapy (FACT) Scales and the Functional Assessment of HIV Infection (FAHI) Scale. Version 3. Chicago, IL: Rush Cancer Institute; 1994.
24. Wyatt GK, Kurtz ME, Friedman LL, Given B, Given CW. Preliminary testing of the Long-term Quality of Life (LTQL) instrument for female cancer survivors. J Nurs Meas. 1996;4(2):153-170.
25. Satariano WA, Ragheb NE, Branch LG, Swanson GM. Difficulties in physical functioning reported by middle-aged and elderly women with breast cancer: a case-control comparison. J Gerontol. 1990;45(1):M3-11.
26. Given CW, Stommel M, Given B, Osuch J, Kurtz ME, Kurtz JC. The inf luence of cancer patient's symptoms and functional status on patient's depression and family caregiver's reaction and depression. Health Psychol. 1993;12(4):277-285.
27. Mendoza T, Wang S, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients. Cancer. 1999;85(5):1186-1196.
28. Cleeland CS. Assessment of pain in cancer: measurement issues. Adv Pain Res Ther. 1990;16:47-55.
29. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto, CA: Mind Garden, Inc; 1983.
30. Radloff LS, Locke BZ. The community mental health assessment survey and the CED-D scale. In: Weissman MM, Meyers JK, Ross CE, eds. Community Surveys of Psychiatric Disorders. New Brunswick, NJ: Rutgers University Press; 1986.
31. Wyatt GK. Complementary therapy use survey (unpublished instrument). East Lansing, MI: Michigan State University; 1993.
32. Calsyn R. A checklist for critiquing treatment fidelity studies. Ment Health Serv Res. 2000;2(2):107-113.
33. Ezzo J. What can be learned from Cochrane systematic reviews of massage that can guide future research. J Altern Complement Med. 2007; 13(2):291-295.
34. Wyatt GK, Sikorskii A, Siddiqi A, et al. Feasibility of a ref lexology and guided imagery intervention during chemotherapy: results of a quasiexperimental study. Oncol Nurs Forum. 2007;34(3):635-642.
35. Kozachik S, Wyatt GK, Given CW, Given B. Patterns of use of complementary therapies among cancer patients and their family caregivers. Cancer Nurs. 2006;29(2):84-94.
36. Wyatt GK, Sikorskii A, Siddiqi A, et al. Feasibility of a reflexology and guided imagery intervention during chemotherapy: Results of a quasiexperimental study. Oncology Nursing Forum. 2007;34(3):635-642.
37. Giasson M, Bouchard L. Effect of therapeutic touch on the well-being of persons with cancer. J Holist Nurs. 1998;16:383-398.
38. Hale EH. A study of the relationship between therapeutic touch and the anxiety levels of hospitalized adults. Diss Abstr Int. 1986;47:1928.
39. Gordon A, Merenstein J, D'Amico F, Hudgens D. The effects of therapeutic touch on patients with osteoarthritis of the knee. J Fam Pract. 1998;47(4):271-277.
40. Turner JG, Clark AJ, Gauthier DK, Williams M. The effect of therapeutic touch on pain and anxiety in burn patients. J Adv Nurs. 1998; 28(1):10-20.
41. Winstead-Fry P, Kijek J. An integrative review and meta-analysis of therapeutic touch research. Altern Ther Health Med. 1999;5(6):58-67.
42. Parkes BS. Therapeutic Touch as an Intervention to Reduce Anxiety in Elderly Hospitalized Patients [dissertation]. Austin, TX: University of Texas at Austin; 1986.
43. Peck SD. The efficacy of therapeutic touch for improving functional ability in elders with degenerative arthritis. Nurs Sci Q. 1998;11(3):123-132.
44. Hodgson H. Does ref lexology impact on cancer patient's quality of life? Nurs Stand. 2000;14(31):33-38.
45. Stephenson N, Weinrich S, Tavakoli A. The effects of foot ref lexology on anxiety and pain inpatients with breast and lung cancer. Oncol Nurs Forum. 2000;27:67-72.
46. Simington JA. Effects of therapeutic touch on anxiety in the institutionalized elderly. Clin Nurs Res. 1993;2(4):438-450.
47. Quinn JF. An Investigation of the Effects of Therapeutic Touch Done Without Physical Contact on State Anxiety of Hospitalized Cardiovascular Patients [dissertation]. New York: School of Education, Health, Nursing and Arts, New York University; 1982.
48. Denison B. Touch the pain away: new research on therapeutic touch and persons with fibromyalgia syndrome. Holist Nurs Pract. 2004;18(3): 142-151.
49. Samarel N, Fawcett J, Davis M, Ryan F. Effects of dialogue and therapeutic touch on preoperative and postoperative experience of breast cancer surgery: an exploratory study. Oncol Nurs Forum. 1998;25(8):1369-1376.
50. Wyatt G, Sikorskii A. Feasibility and Preliminary Efficacy Testing of Therapeutic Touch in Breast Cancer. R21 proposal submitted to National Institutes of Health; 2009.
51. Institute of Medicine. Need for innovative designs in research on CAM and conventional medicine. Complementary and Alternative Medicine in the United States. Washington, DC: National Academies Press; 2005: 108-128.
52. Lee CO. Biomedical, complementary, and alternative medicine: significant issues. Clin J Oncol Nurs. 2004;8(6):670-674.
53. Richardson J. The use of randomized control trials in complementary therapies: exploring the issues. J Adv Nurs. 2000;32(2):398-406.
54. Brody H. The placebo effect: implications for the study and practice of complementary and alternative medicine. In: Callaghan D, ed. The Role of Complementary and Alternative Medicine: Accommodating Pluralism. Washington, DC: Georgetown University Press; 2002:74-83.
55. Carroll KM, Kadden RM, Donovan DM, Zweben A, Rounsaville BJ. Implementing treatment and protecting the validity of the independent variables in treatment matching studies. J Stud Alcohol. 1994;12(suppl): 149-155.
56. Markowitz JC, Spielman LA, Scarvalone PA, Perry SW. Psychotherapy adherence of therapists treating HIV. J Psychother Pract Res. 2000;9(2): 75-80.
57. National Cancer and Complementary Medicine National Institutes of Health. Paying for complementary and alternative medicine treatment: information for patients. J Pain Palliat Care Pharmacother. 2008;22(2):153-157.
58. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE.Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000;18(13):2505-2514.
59. Moncher FJ, Prinz RJ. Treatment fidelity in outcome studies. Clin Psychol Rev. 1991;11:247-267.